Spectral Medical Inc. (EDTXF)
USD 0.57
(-3.03%)
USD 0.57
(-3.03%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 1.59 Million CAD | -4.14% |
| 2022 | 1.66 Million CAD | -18.76% |
| 2021 | 2.05 Million CAD | -2.33% |
| 2020 | 2.1 Million CAD | -26.74% |
| 2019 | 2.86 Million CAD | -25.31% |
| 2018 | 3.84 Million CAD | 0.89% |
| 2017 | 3.8 Million CAD | 7.36% |
| 2016 | 3.54 Million CAD | 14.76% |
| 2015 | 3.08 Million CAD | 4.22% |
| 2014 | 2.96 Million CAD | 10.93% |
| 2013 | 2.67 Million CAD | 3.21% |
| 2012 | 2.58 Million CAD | 1.97% |
| 2011 | 2.53 Million CAD | -10.0% |
| 2010 | 2.82 Million CAD | -14.07% |
| 2009 | 3.28 Million CAD | 9.03% |
| 2008 | 3.01 Million CAD | 0.6% |
| 2007 | 2.99 Million CAD | 37.99% |
| 2006 | 2.16 Million CAD | -78.31% |
| 2005 | 10 Million CAD | -14.89% |
| 2004 | 11.75 Million CAD | -18.89% |
| 2003 | 14.48 Million CAD | 9.43% |
| 2002 | 13.23 Million CAD | 20.66% |
| 2001 | 10.97 Million CAD | 11.96% |
| 2000 | 9.8 Million CAD | -6.67% |
| 1999 | 10.5 Million CAD | 98.11% |
| 1998 | 5.3 Million CAD | 253.33% |
| 1997 | 1.5 Million CAD | 150.0% |
| 1996 | 600 Thousand CAD | 20.0% |
| 1995 | 500 Thousand CAD | 150.0% |
| 1994 | 200 Thousand CAD | 100.0% |
| 1993 | 100 Thousand CAD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 668 Thousand CAD | 83.01% |
| 2024 Q2 | 471 Thousand CAD | -29.49% |
| 2023 Q3 | 397 Thousand CAD | 29.74% |
| 2023 FY | 1.59 Million CAD | -4.14% |
| 2023 Q4 | 365 Thousand CAD | -8.06% |
| 2023 Q1 | 530 Thousand CAD | 1.34% |
| 2023 Q2 | 306 Thousand CAD | -42.26% |
| 2022 Q1 | 484 Thousand CAD | -6.38% |
| 2022 Q2 | 286 Thousand CAD | -40.91% |
| 2022 Q3 | 374 Thousand CAD | 30.77% |
| 2022 FY | 1.66 Million CAD | -18.76% |
| 2022 Q4 | 523 Thousand CAD | 39.84% |
| 2021 Q2 | 559 Thousand CAD | -25.07% |
| 2021 FY | 2.05 Million CAD | -2.33% |
| 2021 Q4 | 517 Thousand CAD | 124.78% |
| 2021 Q3 | 230 Thousand CAD | -58.86% |
| 2021 Q1 | 746 Thousand CAD | 39.44% |
| 2020 Q2 | 517 Thousand CAD | -18.07% |
| 2020 FY | 2.1 Million CAD | -26.74% |
| 2020 Q4 | 535 Thousand CAD | 27.99% |
| 2020 Q1 | 631 Thousand CAD | -15.42% |
| 2020 Q3 | 418 Thousand CAD | -19.15% |
| 2019 Q2 | 1.04 Million CAD | 90.31% |
| 2019 Q1 | 547 Thousand CAD | -70.65% |
| 2019 Q4 | 746 Thousand CAD | 39.7% |
| 2019 FY | 2.86 Million CAD | -25.31% |
| 2019 Q3 | 534 Thousand CAD | -48.7% |
| 2018 Q1 | 1.16 Million CAD | 26.69% |
| 2018 FY | 3.84 Million CAD | 0.89% |
| 2018 Q4 | 1.86 Million CAD | 221.93% |
| 2018 Q3 | 579 Thousand CAD | 147.44% |
| 2018 Q2 | 234 Thousand CAD | -79.88% |
| 2017 Q4 | 918 Thousand CAD | 7.12% |
| 2017 Q1 | 941 Thousand CAD | 16.75% |
| 2017 Q2 | 1.09 Million CAD | 15.83% |
| 2017 Q3 | 857 Thousand CAD | -21.38% |
| 2017 FY | 3.8 Million CAD | 7.36% |
| 2016 Q1 | 1.06 Million CAD | 48.53% |
| 2016 Q2 | 870 Thousand CAD | -18.08% |
| 2016 Q4 | 806 Thousand CAD | -0.12% |
| 2016 Q3 | 807 Thousand CAD | -7.24% |
| 2016 FY | 3.54 Million CAD | 14.76% |
| 2015 Q2 | 818 Thousand CAD | -6.73% |
| 2015 Q1 | 877 Thousand CAD | 25.46% |
| 2015 FY | 3.08 Million CAD | 4.22% |
| 2015 Q4 | 715 Thousand CAD | 5.3% |
| 2015 Q3 | 679 Thousand CAD | -16.99% |
| 2014 Q4 | 699 Thousand CAD | 8.71% |
| 2014 Q1 | 844 Thousand CAD | 18.37% |
| 2014 Q2 | 778 Thousand CAD | -7.82% |
| 2014 Q3 | 643 Thousand CAD | -17.35% |
| 2014 FY | 2.96 Million CAD | 10.93% |
| 2013 Q1 | 708 Thousand CAD | 9.43% |
| 2013 Q4 | 713 Thousand CAD | 5.01% |
| 2013 Q3 | 679 Thousand CAD | 18.71% |
| 2013 Q2 | 572 Thousand CAD | -19.21% |
| 2013 FY | 2.67 Million CAD | 3.21% |
| 2012 Q4 | 647 Thousand CAD | -3.0% |
| 2012 FY | 2.58 Million CAD | 1.97% |
| 2012 Q3 | 667 Thousand CAD | 11.35% |
| 2012 Q2 | 599 Thousand CAD | -11.39% |
| 2012 Q1 | 676 Thousand CAD | 1.2% |
| 2011 Q4 | 668 Thousand CAD | 31.5% |
| 2011 Q2 | 714 Thousand CAD | 10.02% |
| 2011 FY | 2.53 Million CAD | -10.0% |
| 2011 Q1 | 649 Thousand CAD | -3.57% |
| 2011 Q3 | 508 Thousand CAD | -28.85% |
| 2010 Q4 | 673 Thousand CAD | -6.79% |
| 2010 Q2 | 678 Thousand CAD | -9.36% |
| 2010 FY | 2.82 Million CAD | -14.07% |
| 2010 Q1 | 748 Thousand CAD | -12.0% |
| 2010 Q3 | 722 Thousand CAD | 6.49% |
| 2009 Q3 | 815 Thousand CAD | 5.03% |
| 2009 Q1 | 842 Thousand CAD | -2.21% |
| 2009 Q2 | 776 Thousand CAD | -7.84% |
| 2009 FY | 3.28 Million CAD | 9.03% |
| 2009 Q4 | 850 Thousand CAD | 4.29% |
| 2008 Q1 | 664 Thousand CAD | -1.63% |
| 2008 Q4 | 861 Thousand CAD | 22.82% |
| 2008 Q3 | 701 Thousand CAD | -10.7% |
| 2008 Q2 | 785 Thousand CAD | 18.22% |
| 2008 FY | 3.01 Million CAD | 0.6% |
| 2007 FY | 2.99 Million CAD | 37.99% |
| 2007 Q2 | 738 Thousand CAD | -12.25% |
| 2007 Q4 | 675 Thousand CAD | -8.66% |
| 2007 Q3 | 739 Thousand CAD | 0.14% |
| 2007 Q1 | 841 Thousand CAD | 0.0% |
| 2006 FY | 2.16 Million CAD | -78.31% |
| 2006 Q2 | 747 Thousand CAD | -25.82% |
| 2006 Q1 | 1 Million CAD | -41.01% |
| 2006 Q3 | 675 Thousand CAD | -9.64% |
| 2005 Q3 | 2.26 Million CAD | -1.22% |
| 2005 Q4 | 1.7 Million CAD | -24.64% |
| 2005 FY | 10 Million CAD | -14.89% |
| 2005 Q1 | 2.35 Million CAD | 1.69% |
| 2005 Q2 | 2.29 Million CAD | -2.51% |
| 2004 Q1 | 3.13 Million CAD | 6.05% |
| 2004 FY | 11.75 Million CAD | -18.89% |
| 2004 Q4 | 2.31 Million CAD | -6.96% |
| 2004 Q3 | 2.48 Million CAD | -12.74% |
| 2004 Q2 | 2.84 Million CAD | -9.21% |
| 2003 FY | 14.48 Million CAD | 9.43% |
| 2003 Q2 | 3.15 Million CAD | -1.96% |
| 2003 Q3 | 2.5 Million CAD | -20.68% |
| 2003 Q4 | 2.95 Million CAD | 18.31% |
| 2003 Q1 | 3.21 Million CAD | -25.21% |
| 2002 FY | 13.23 Million CAD | 20.66% |
| 2002 Q4 | 4.3 Million CAD | 0.16% |
| 2002 Q3 | 4.29 Million CAD | 60.25% |
| 2002 Q2 | 2.67 Million CAD | -2.15% |
| 2002 Q1 | 2.73 Million CAD | -1.76% |
| 2001 FY | 10.97 Million CAD | 11.96% |
| 2001 Q1 | 2.88 Million CAD | -9.08% |
| 2001 Q2 | 5.24 Million CAD | 81.96% |
| 2001 Q3 | 2.46 Million CAD | -52.95% |
| 2001 Q4 | 2.78 Million CAD | 12.93% |
| 2000 FY | 9.8 Million CAD | -6.67% |
| 2000 Q3 | 2.46 Million CAD | -1.52% |
| 2000 Q4 | 3.17 Million CAD | 28.8% |
| 2000 Q1 | 2.6 Million CAD | -18.75% |
| 2000 Q2 | 2.5 Million CAD | -3.85% |
| 1999 Q2 | 2.1 Million CAD | -32.26% |
| 1999 Q4 | 3.2 Million CAD | 68.42% |
| 1999 FY | 10.5 Million CAD | 98.11% |
| 1999 Q1 | 3.1 Million CAD | 14.81% |
| 1999 Q3 | 1.9 Million CAD | -9.52% |
| 1998 Q3 | 2 Million CAD | -23.08% |
| 1998 Q4 | 2.7 Million CAD | 35.0% |
| 1998 Q2 | 2.6 Million CAD | 18.18% |
| 1998 Q1 | 2.2 Million CAD | 37.5% |
| 1998 FY | 5.3 Million CAD | 253.33% |
| 1997 FY | 1.5 Million CAD | 150.0% |
| 1997 Q4 | 1.6 Million CAD | 60.0% |
| 1997 Q3 | 1 Million CAD | 100.0% |
| 1997 Q1 | 500 Thousand CAD | 0.0% |
| 1997 Q2 | 500 Thousand CAD | 0.0% |
| 1996 Q1 | 100 Thousand CAD | 0.0% |
| 1996 Q4 | 500 Thousand CAD | 25.0% |
| 1996 FY | 600 Thousand CAD | 20.0% |
| 1996 Q3 | 400 Thousand CAD | 300.0% |
| 1996 Q2 | 100 Thousand CAD | 0.0% |
| 1995 FY | 500 Thousand CAD | 150.0% |
| 1995 Q4 | 100 Thousand CAD | -50.0% |
| 1995 Q1 | 100 Thousand CAD | 0.0% |
| 1995 Q3 | 200 Thousand CAD | 0.0% |
| 1995 Q2 | 200 Thousand CAD | 100.0% |
| 1994 Q1 | 100 Thousand CAD | 0.0% |
| 1994 Q3 | 300 Thousand CAD | 200.0% |
| 1994 Q4 | 100 Thousand CAD | -66.67% |
| 1994 FY | 200 Thousand CAD | 100.0% |
| 1994 Q2 | 100 Thousand CAD | 0.0% |
| 1993 Q4 | 100 Thousand CAD | 0.0% |
| 1993 FY | 100 Thousand CAD | 0.0% |
| 1993 Q1 | -27.7 Thousand CAD | -121.7% |
| 1993 Q3 | 100 Thousand CAD | 0.0% |
| 1993 Q2 | 100 Thousand CAD | 460.91% |
| 1992 Q3 | 124.78 Thousand CAD | 4.32% |
| 1992 Q2 | 119.61 Thousand CAD | 0.0% |
| 1992 Q4 | 127.7 Thousand CAD | 2.34% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| American Bio Medica Corporation | 913 Thousand USD | -75.027% |
| Arrayit Corporation | 4.37 Million USD | 63.493% |
| Atlantic International Corp. | - USD | -Infinity% |
| Biocept, Inc. | 25.85 Million USD | 93.82% |
| Bioqual, Inc. | 58.59 Million USD | 97.273% |
| CardioGenics Holdings Inc | - USD | -Infinity% |
| DermTech, Inc. | 15.29 Million USD | 89.553% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 7.38 Billion USD | 99.978% |
| HTG Molecular Diagnostics, Inc. | 6.36 Million USD | 74.899% |
| iMD Companies, Inc. | - USD | -Infinity% |
| IDenta Corp. | 1.05 Million USD | -51.96% |
| Interpace Biosciences, Inc. | 40.21 Million USD | 96.026% |
| Integrative Health Technologies, Inc. | 447.49 Thousand USD | -257.096% |
| InVitro International | 792.62 Thousand USD | -101.608% |
| Lumos Diagnostics Holdings Limited | 11.13 Million USD | 85.644% |
| Many Bright Ideas Technologies Inc. | - USD | -Infinity% |
| Medical Imaging Corp. | 7.22 Million USD | 77.88% |
| NovelStem International Corp. | 12 Thousand USD | -13216.667% |
| Optigenex Inc. | 465.97 Thousand USD | -242.941% |
| PharmChem, Inc. | 6.01 Million USD | 73.422% |
| Proteome Sciences plc | 6.4 Million USD | 75.034% |
| Response Genetics, Inc | 18.04 Million USD | 91.142% |
| Rennova Health, Inc. | 13.03 Million USD | 87.742% |
| RushNet, Inc. | 1.78 Million USD | 10.62% |
| ScreenPro Security Inc. | 1.91 Million USD | 16.514% |
| Stella Diagnostics Inc. | - USD | -Infinity% |
| StageZero Life Sciences Ltd. | 3.79 Million USD | 57.893% |
| Todos Medical Ltd. | 7.69 Million USD | 79.233% |